The Abelson non-receptor tyrosine kinase (c-Abl, Abl1) is normally activated in the Bcr–Abl hybrid protein of chronic myelogenous leukemia (CML). This evidence concerns the gene BCR and chronic myelogenous leukemia, BCR-ABL1 positive.